NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) — Kirby McInerney LLP<\/a> reminds ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ:IBRX) investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions.<\/p>\n If you purchased or otherwise acquired ImmunityBio securities, have information, or would like to learn more, please contact Lauren Molinaro<\/a> of Kirby McInerney LLP by email at investigations@kmllp.com<\/a>, or fill out the form below, to discuss your rights or interests.<\/p>\n [CONTACT THE FIRM IF YOU SUFFERED A LOSS<\/a>]<\/p>\n What Is The Lawsuit About?<\/strong><\/p>\n The lawsuit has been filed on behalf of investors who purchased securities during the period of January 19, 2026 through March 24, 2026, inclusive (\u201cthe Class Period\u201d). The lawsuit alleges that (1) Defendant Patrick Soon-Shiong, the Company\u2019s Executive Chairman of the Board, materially overstated the capabilities of Anktivas, an FDA-approved IL-15 receptor agonist immunotherapy that combats cancer, in public statements.<\/p>\n On March 24, 2026, before markets opened, the United States Food and Drug Administration (\u201cFDA\u201d) issued a warning letter to ImmunityBio. The FDA stated in the warning letter that a TV ad and podcast, which can be accessed through ImmunityBio\u2019s website, has been determined to be \u201cfalse or misleading.\u201d The FDA also stated that \u201cUntitled Letters dated September 9, 2025, and January 7, 2026\u201d were sent to \u201cAltor BioScience, LLC (an indirect wholly-owned subsidiary of ImmunityBio, Inc.) [which] addressed presentations of Anktiva that were, in certain respects, similar to presentations in the TV ad and podcast addressed in this [warning] letter.\u201d \u201c[D]espite receiving these previous Untitled Letters, ImmunityBio continues to promote Anktiva in a similarly misleading manner. On this news, the price of ImmunityBio shares declined by $1.99 per share, or approximately 21.2%, from $9.40 per share on March 23, 2026 to close at $7.41 on March 24, 2026.<\/p>\n [CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION<\/a>]<\/p>\n What Should I Do?<\/strong><\/p>\n If you purchased or otherwise acquired ImmunityBio securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro<\/a> of Kirby McInerney LLP<\/a> by email at investigations@kmllp.com<\/a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.<\/p>\n [WHAT IS A SECURITIES CLASS ACTION?<\/a>]<\/p>\n Kirby McInerney LLP<\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP\u2019s website<\/a>.<\/p>\n This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n Contacts NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) — Kirby McInerney LLP reminds ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ:IBRX) investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation […]<\/p>\n","protected":false},"author":3,"featured_media":409155,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/192da1d1-643f-4eee-b850-dde5b9f2b00f","fifu_image_alt":"","footnotes":""},"categories":[57166],"tags":[],"class_list":["post-409154","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"_links":{"self":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/409154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/comments?post=409154"}],"version-history":[{"count":0,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/409154\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/media\/409155"}],"wp:attachment":[{"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/media?parent=409154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/categories?post=409154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailybanglanewspapers.com\/news\/wp-json\/wp\/v2\/tags?post=409154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Kirby McInerney LLP\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
Lauren Molinaro, Esq.
212-699-1171
https:\/\/www.kmllp.com<\/a>
https:\/\/securitiesleadplaintiff.com\/<\/a>
investigations@kmllp.com<\/a><\/p>\n![\"\"](\"https:\/\/ml.globenewswire.com\/media\/Y2FkMDFmYWUtYzJjZC00NzY4LTllMTAtMDYxODc2MjY5NWJlLTEwMzE5OTctMjAyNi0wNC0xNi1lbg==\/tiny\/Kirby-McInerney-LLP.png\")
\n <\/div>\n","protected":false},"excerpt":{"rendered":"